Call Number (LC) | Title | Results |
---|---|---|
RM301.25 .D78 2012eb |
Drug Repositioning Bringing New Life to Shelved Assets and Existing Drugs Drug repositioning : bringing new life to shelved assets and existing drugs / Drug discovery from natural products |
3 |
RM301.25 .D78 2013eb | Drug repurposing and repositioning : workshop summary / | 1 |
RM301.25 .D78 2024 | Drug utilization research : methods and applications / | 1 |
RM301.25 .D783 1948i | Drug research and development | 1 |
RM301.25 .D783 2008eb | Drug discovery and evaluation pharmacological assays / | 1 |
RM301.25 .D783 2013 | Drug discovery and development : technology in transition / | 1 |
RM301.25 .D784 2005 | Drug discovery handbook / | 2 |
RM301.25 .D786 2004eb | Drug discovery strategies and methods / | 1 |
RM301.25 .D786148 2017eb | Drug repositioning : approaches and applications for neurotherapeutics / | 1 |
RM301.25 .E27 2010eb |
Early drug development strategies and routes to first-in-human trials / Early drug development : strategies and routes to first-in-human trials / |
2 |
RM301.25 .E53 2018 | Encyclopedia of biopharmaceutical statistics / | 1 |
RM301.25 .E533 2017 | Enabling Precision Medicine : the Role of Genetics in Clinical Drug Development: Proceedings of a Workshop. | 1 |
RM301.25 .E87 | European journal of pharmaceutical sciences | 1 |
RM301.25 .E93 2010 |
Evaluation of drug candidates for preclinical development : pharmacokinetics, metabolism, pharmaceutics, and toxicology / Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology / |
2 |
RM301.25 .E95 2013 | Evidence and rational based research on Chinese drugs | 1 |
RM301.25 .E97 2024 | Exploring computational pharmaceutics : AI and modeling in Pharma 4.0 / | 1 |
RM301.25 .F37 2008eb | FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics / | 1 |
RM301.25 .F56 2021 | Flow chemistry in drug discovery / | 1 |
RM301.25 .F67 2012 | Formulating poorly water soluble drugs | 1 |
RM301.25 .F67 2016eb | Formulating poorly water soluble drugs / | 1 |